Werner syndrome RecQ helicase-IN-3 |
Katalog-Nr.GC70142 |
Werner-Syndrom RecQ-Helicase-IN-3 ist ein wirksamer, oral aktiver Inhibitor der Werner-Syndrom RecQ-DNA-Helikase WRN mit einer IC50 von 0,06 µM. Werner-Syndrom RecQ-Helicase-IN-3 zeigt antiproliferative Aktivität und hat eine anti-karzinogene Wirkung.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2869954-98-1
Sample solution is provided at 25 µL, 10mM.
Review for Werner syndrome RecQ helicase-IN-3
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Werner syndrome RecQ helicase-IN-3
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *